Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study
Titel:
Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study
Auteur:
Kovacs, Richard J. Maldonado, Giuliana Azaro, Analia Fernández, Maria S. Romero, Federico L. Sepulveda-Sánchez, Juan M. Corretti, Mary Carducci, Michael Dolan, Melda Gueorguieva, Ivelina Cleverly, Ann L. Pillay, N. Sokalingum Baselga, Jose Lahn, Michael M.